Hypertension, Vol 7, 81-89, Copyright © 1985 by American Heart Association
JL Cuche, J Prinseau, F Selz, G Ruget, JL Tual, L Reingeissen, M Devoisin, A Baglin, J Guedon and D Fritel
The levels of free and sulfoconjugated catecholamines were measured in the
plasma of fasting, recumbent normal subjects before and after an oral load
of the catecholamine precursors tyrosine or L-dopa. Basal values of
sulfoconjugated catecholamines, measured in plasma samples diluted 1:100
were 7998 +/- 540 pg/ml for dopamine sulfate, 2938 +/- 281 pg/ml for
norepinephrine sulfate, and 2958 +/- 288 pg/ml for epinephrine sulfate (n =
37 tests in 15 men); these basal values are higher than those reported
previously. Neither free nor sulfoconjugated catecholamine concentrations
were changed by a tyrosine load (100 mg/kg) that induced a doubling of the
plasma tyrosine level or by a meal low in phenylalanine and tyrosine (but
otherwise supplying constituents of normal nourishment) that induced a
greater than 50% reduction in the plasma tyrosine concentration. After an
oral load of L- dopa (125 mg) the following were observed. (1) An extremely
large increase (greater than 100-fold) in dopamine sulfate levels was
noted, an increase that was less marked in the same subjects given L-dopa
(125 mg) plus the peripheral dopa-decarboxylase inhibitor carbidopa (12.5
mg); as expected, free dopamine concentration also was increased. (2)
Neither free nor sulfoconjugated norepinephrine concentrations were
altered. (3) Epinephrine sulfate but not free epinephrine concentration was
increased (more than ten-fold) after L-dopa ingestion alone; this result
was unexpected and has to be confirmed before considering its physiological
meaning, if any.
ARTICLES
Oral load of tyrosine or L-dopa and plasma levels of free and sulfoconjugated catecholamines in healthy men
This article has been cited by other articles:
![]() |
O. Kuchel Differential catecholamine responses to protein intake in healthy and hypertensive subjects Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1164 - R1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Martel, P. Ponchon, P. Champeroux, J.-L. Elghozi, J.-F. R. De La Faverie, H. Dabire, B. Pannier, S. Richard, M. Safar, and J.-L. Cuche Mechanisms of the cardiovascular deconditioning induced by tail suspension in the rat Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1667 - H1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Saito, H. Kawabe, C. Hasegawa, Y. Iwaida, H. Yamakawa, T. Saruta, E. Takeshita, S. Nagano, and T. Sekihara Effect of L-dopa in Young Patients with Hypertension Angiology, September 1, 1991; 42(9): 691 - 695. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |